SEC Filing Details
PTC Therapeutics, Inc. is committed to serving the interests of all our stakeholders.
Living with
Duchenne Muscular Dystrophy,
Ukraine
SEC Filing Details
Document Details
Form
Filing Date
Sep 8, 2023
Document Date
Sep 6, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
PTC Therapeutics, Inc.
Issuer
PTC THERAPEUTICS, INC.
Filer
YOUNG ALETHIA